Verve Therapeutics Inc (VERV)

34.01 +0.76  +2.29% NASDAQ Nov 30, 10:42 USD

Verve Therapeutics Total Expenses (TTM)

View 4,000+ financial data types
Browse...

Historical Total Expenses (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 Upgrade
June 30, 2021 Upgrade
   
March 31, 2021 Upgrade
Dec. 31, 2020 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View Total Expenses (TTM) for VERV

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

Advertisement

Total Expenses Definition

A company's expenses are how much a company is spending before its net income. This is a useful metric to compare a company spending habits over time. Starting from the income statement, a company may have a considerable amount of revenues. As an investor goes down the Income Statement, gradually line items such as

Read full definition.

Total Expenses (TTM) Range, Past 5 Years

Minimum Upgrade Dec 2020
Maximum Upgrade Sep 2021
Average Upgrade

News

Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.